Mudryk Appeals Four‑Year Doping Ban, Seeks Early Return

*TL;DR: Chelsea’s £88 million winger Mykhailo Mudryk has lodged a Court of Arbitration for Sport appeal against a four‑year doping ban, aiming for a return possibly next season.

Context The Football Association imposed the maximum four‑year suspension on the 25‑year‑old Ukrainian after a routine urine test flagged the cardiovascular drug meldonium in October 2024. The ban, back‑dated to his provisional suspension in December 2024, would keep Mudryk out until December 2028.

Key Facts - The Court of Arbitration for Sport confirmed receipt of Mudryk’s appeal on 25 February 2026 and is now handling written submissions; a hearing date has not been set. - The FA’s sanction represents the harshest penalty for a doping violation in English football. - Chelsea purchased Mudryk for £88 million in January 2023; his contract runs for five more years, securing the club’s financial stake. - Mudryk has not played for Chelsea since November 2024, when he appeared in a Conference League match against Heidenheim. - Sources close to the player suggest an appeal could shorten the ban, potentially allowing a comeback in the 2026‑27 season.

What It Means The appeal introduces uncertainty for both Chelsea and the Premier League. If CAS reduces the suspension, Chelsea could reactivate a high‑value asset before his contract expires, preserving the £88 million investment. Conversely, a upheld ban would extend his absence, forcing the club to consider a replacement or a loan to mitigate the loss of a contracted player.

For Mudryk, the legal process offers a chance to contest the finding that meldonium, a medication that can boost stamina, entered his system during national‑team duty. A successful reduction could restore his eligibility and market value, while a denial would cement a four‑year hiatus.

Looking Ahead Watch for the scheduling of the CAS hearing and any interim rulings that could affect Mudryk’s eligibility for the upcoming transfer window.